Nhlbi Clinical Investigator Award Program

Stump, David C.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 5K08HL001489-03
• Application #: 3081847
• Study Section: (SRC)
• Project Start: 1984-07-01
• Project End: 1988-06-30
• Budget Start: 1985-07-01
• Budget End: 1986-06-30
• Support Year: 3
• Fiscal Year: 1985

Institution

• Name: University of Vermont & St Agric College
• Type: Schools of Medicine
• DUNS #: 066811191
• City: Burlington
• State: VT
• Country: United States

Publications

Topol, E J; Ellis, S G; Califf, R M et al. (1989) Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. J Am Coll Cardiol 14:877-84

Stump, D C; Califf, R M; Topol, E J et al. (1989) Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group. Circulation 80:1222-30

Dzik, W H; Arkin, C F; Jenkins, R L et al. (1988) Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood 71:1090-5

Stump, D C; Topol, E J; Chen, A B et al. (1988) Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator. Thromb Haemost 59:133-7

Topol, E J; George, B S; Kereiakes, D J et al. (1988) Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction. Am J Cardiol 61:723-8

Heeb, M J; Espana, F; Geiger, M et al. (1987) Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 262:15813-6